참고문헌
- Bruix J (1997). Treatment of hepatocellular carcinoma. Hepatology, 25, 259-62. https://doi.org/10.1002/hep.510250201
- Camma C, Schepis F, Orlando A, et al (2008). Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology, 224, 47-54.
- chen MS, Li JQ, Zhang YQ, et al (2002). High does iozedized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma. World J Gastroenterol, 8, 74.
- Chen Y, Feng Y, Dai L, et al (2003). Screening and evaluation of non-traumatic diagnostic indexes to compensatory hepatic cirrhosis. Chinese Hapar Disease J, 11, 220-5.
- Chung JW, Park JH, Han JK, et al (2007). Hepatic tumors: predisposing fators for complications of transeatheter oily chemoembolization. Radiology, 198, 33-40.
- Chung JW, Park JH, Han JK, et al (1996). Hepatic tumors: predispo sing factors for complications of transcatheter oily chemoembolization. Radiology, 198, 33-40. https://doi.org/10.1148/radiology.198.1.8539401
- Feng G, Wu H, Xu L, et al (2002). The related to the fibrotic indicators of primary hepatocellular carcinoma patients after transcatheter arterial chemoembolization. Chinese J of Hepatobiliary Surg, 8, 414-6.
- Hu D, Li Z, Wang N, et al (2002). TACE treatment of Hepatic Carcinoma: A Comparative study of low dose versus conventional dose. Clin Radiol J, 23, 502-6.
- Ikeda K, Kumada H, Saitoh S, et al (2001). Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma: an analysis by the cox proportional hazard model. Cancer, 68, 2150-4.
- Kamada K, Nakanishi T, Kitamoto M, et al (2001). Long-term prognosis of patients undergoing transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: comparison of cisplatin lipiodol suspension and doxorubicin hydrochloride emulsion. J Vasc Interv Radiol, 12, 847-54. https://doi.org/10.1016/S1051-0443(07)61510-3
- Kamada K, Nakanishi T, Kitamato M, et al (2009). Long-term prognosis of patients undergoing transcatheter arterial chenmoembolization for unresectable hepatocellular carcinoma: comparison of cisplatin liopiodol suspension and doxorubicin hydrocholoride emulsion. J Vasc Interv Radiol, 12, 843-7.
- Li H, Hu D, Zhao Y, et al (2000). The relationship between curative effect of hepatic arterial chemoembolization and dose of Iodized Oil. China Hepatol J, 12, 235-6.
- Lu W, Li Y, He X, et al (2004). A comparative study on the changes of serum fibrosis indicators after TACE with use of low-dose versus conventional-dose of anticancer drugs in hepatocellular carcinoma. J Interv Radiol, 13, 247-9.
- Lu W, Lu S (2006). Progress in diagnosis and treatment of liver fibrosis. Int J Digest Dis, 26, 13-6.
- Lu W, Li Y (2002). Hepatic carcinoma treated with trancatheter arterial chemoembolization. Clin Radiol J, 21, 735.
- Lu W, Li Y, Li Z, et al (2003). A comparative study on necrosis and apoptosis of hepatocellular carcinoma cells after TACE with use of low-dose and conventional-dose anticancer drugs. Chinese J Radiol, 37, 232-7.
- Therasse P, Arbuck SG, Eisenhauer EA, et al (2000). New guide lines to evaluate the response to treatment in solidtumors. JNCI, 92, 205-16. https://doi.org/10.1093/jnci/92.3.205
- Xiao C, Zheng L, Jiang X, et al (1997). Observation of liver damage caused by hepatic arterial chemoembolization. China Radiol J, 31, 777-9.
- Yan L (2002). Liver Surgery. Peking: The People's Medical Publishing House, 263-509.
- Zhu S, Shan H, Huang M, et al (2000). The content changes of serum liver fibrosis indicators after transarterial chemoembolization for primary hepatic carcinoma and their clinical significance. J Clin Radiol, 19, 208-9.
피인용 문헌
- Impact of Low Versus Conventional Doses of Chemotherapy During Transcatheter Arterial Chemo-embolization on Serum Fibrosis Indicators and Survival of Liver Cancer Patients vol.13, pp.9, 2012, https://doi.org/10.7314/APJCP.2012.13.9.4757
- Roles of Fibroblast Growth Factor-inducible 14 in Hepatocellular Carcinoma vol.14, pp.6, 2013, https://doi.org/10.7314/APJCP.2013.14.6.3509
- Therapeutic value of transcatheter arterial chemoembolization combined with portal vein embolization for primary hepatocellular carcinoma with portal vein tumor thrombus: A pilot study vol.11, pp.3, 2015, https://doi.org/10.1111/ajco.12272
- Hepatitis B Virus DNA Negativity Acts as a Favorable Prognostic Factor in Hepatocellular Carcinoma Patients vol.15, pp.22, 2014, https://doi.org/10.7314/APJCP.2014.15.22.9635
- Drainage Alone or Combined with Anti-tumor Therapy for Treatment of Obstructive Jaundice Caused by Recurrence and Metastasis after Primary Tumor Resection vol.15, pp.6, 2014, https://doi.org/10.7314/APJCP.2014.15.6.2681
- Schedule-Dependent Effects of Kappa-Selenocarrageenan in Combination with Epirubicin on Hepatocellular Carcinoma vol.15, pp.8, 2014, https://doi.org/10.7314/APJCP.2014.15.8.3651
- Transcatheter Arterial Chemoembolization Combined with Interferon-α is Safe and Effective for Patients with Hepatocellular Carcinoma after Curative Resection vol.16, pp.1, 2015, https://doi.org/10.7314/APJCP.2015.16.1.245
- Transarterial chemoembolization aggravated peritumoral fibrosis via hypoxia-inducible factor-1α dependent pathway in hepatocellular carcinoma vol.30, pp.5, 2015, https://doi.org/10.1111/jgh.12873
- Radiofrequency ablation combined with transcatheter therapy in rabbit VX2 liver tumors: effects and histopathological characteristics vol.56, pp.1, 2015, https://doi.org/10.1177/0284185113520266